Related Experiment Video

Updated: Jul 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Genetic basis of hypertrophic cardiomyopathy

Joanne M Lind1, Christine Chiu, Christopher Semsarian

  • 1University of Sydney, Faculty of Medicine, Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Locked Bag No. 6, Newtown, NSW 2042, Australia. j.lind@centenary.usyd.edu.au

Expert Review of Cardiovascular Therapy
|December 19, 2006
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition causing left ventricle thickening and sudden cardiac death in young adults. Research aims to identify more genes and understand disease mechanisms for better diagnostics and treatments.

Area of Science:

  • Cardiovascular Genetics
  • Genetic Cardiology
  • Molecular Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is the first identified genetic cardiovascular disorder.
  • It is characterized by left ventricle thickening and is a leading cause of sudden cardiac death in individuals under 35.
  • HCM is predominantly a sarcomeric disease, with over 250 mutations identified in 13 sarcomere-related genes.

Purpose of the Study:

  • To identify additional causative genes for Hypertrophic cardiomyopathy.
  • To elucidate signaling mechanisms in HCM pathogenesis.
  • To investigate factors modifying the clinical phenotype of HCM.

Main Methods:

  • Genetic screening of known HCM-associated genes.
  • Ongoing research into novel gene identification.
  • Studies on signaling pathways and genetic modifiers.

Main Results:

  • Genetic screening identifies mutations in up to 60% of HCM cases.
  • Over 250 mutations are known in 13 sarcomere-related genes.
  • Research is actively expanding the genetic landscape of HCM.

Conclusions:

  • Understanding HCM genetics is crucial for improved diagnostics and therapeutics.
  • Identifying new genes and pathways will advance disease understanding.
  • Targeted research may lead to disease prevention and curative treatments for HCM.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...